The White House today released a preliminary planning guide to inform jurisdictional, federal partner and pharmacy planning to distribute the Pfizer COVID-19 vaccine for children aged 6 months through 4 should the Food and Drug Administration authorize the vaccine for emergency use in this age group. According to the guide, pharmacies may have limited ability to vaccinate these younger children, so encouraging Vaccines for Children providers to enroll as COVID-19 vaccine providers will be critical to ensuring access to the vaccine. States will determine what locations receive the vaccine, as they have for previously authorized groups. The federal government and manufacturer plan to provide additional training to prepare participating providers and locations. The administration expects to update the guide as more information or COVID-19 vaccines for this age group become available. 
 

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…